Bristol-Myers Squibb Company (BMY): A Bull Case Theory

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company (BMY)'s share was trading at $56.29 as of Jan 17^th. BMY’s trailing and forward P/E were 22.79 and 7.93 respectively according to Yahoo Finance.

[caption id="attachment_1236609" align="aligncenter" width="768"] A scientist in a lab, researching for a breakthrough treatment for Alzheimer's disease, diabetes nephropathy, asthma, COPD, NASH, and Type 1...